Research supported by:
Why Early Detection
To treat a disease, we must first know the condition exists. The earlier, the better.
Diagnosing brain disorders at their earliest stages enables YOU and your care team to make valuable course-corrections. Minimizing the disease’s negative impacts and maximizing your quality time with loved ones.
The ultimate goal is to unite with researchers and scientists, creating a mighty alliance to race for a cure.
Alzheimer's Test
For people with a family history of Alzheimer’s or who have suffered head injuries, getting an early diagnosis is absolutely life-changing.
Why? Because an accurate diagnosis – decades before symptoms – puts you in the driver’s seat to slow or stop the onset of symptoms.
Did you know that by delaying symptom onset by just 5 years – through lifestyle, diet, and exercise changes – we could reduce the number of people with active Alzheimer’s by 42%?
That’s over 2 million people in the US alone!
Lewy Body Dementia Test
Lewy Body Dementia (LBD) is a newly discovered, maddeningly elusive brain disease. Up until now, it has been impossible to detect, let alone diagnose early.
LBD patients and the loved ones bear the heavy burden of unknowing. They endure long periods of uncertain diagnosis, causing tremendous frustration and emotional, financial, and physical stress. Misdiagnosis happens too often even amongst the most experienced physicians.
Amprion’s game-changing LBD biomarker test provides true answers. A precise diagnosis eliminates all the guesswork and kickstarts a patient’s preventive care journey. So you can have quadratical (means a lot more) quality time.
We help doctors help patients.
Parkinson’s Test
Does Parkinson’s run in your family? Until now, determining whether a person had PD took a long time, a lot of money, deep frustration – and more often than not – was misdiagnosed.
Getting an accurate diagnosis early – decades before symptoms – gives you a leg-up to slow the disease progression.
The key is to know with certainty, then take control and manage the disease, so you stay ahead of the game!
How It Works
Fascinating science stuff put simply: We track the prion-protein biomarkers driving Alzheimer’s, Parkinson’s, and related brain diseases.
Using cerebral spinal fluid (CSF) has a HUGE advantage–Track the prions before they breach the blood-brain barrier! We detect the disease months, years, decades before symptoms appear.
Knowing early is the key. It gives YOU precious extra time and plenty of well-informed options to jumpstart your preventive care.
Alzheimer’s & Parkinson’s - A Crushing Public Health Crisis
Every 33 seconds, one American will be diagnosed with Alzheimer’s! This is what we face if nothing changes by 2050. This number adds to the millions of patients who, as of yet, have no cure.
Today, 5 million people in the US are diagnosed with Alzheimer’s, and 1 million with Parkinson’s. These numbers are expected to triple by 2050.
Despite colossal drug development spending of over $100 billion in the US alone, there’s no cure in sight for Alzheimer’s, Parkinson’s, and other brain diseases.
Make an Impact!
Be a Part of Big Brain Research
Every Alzheimer’s, Parkinson’s, and LBD patient is unique. To treat each individual properly, we need personalized medicine.
We must first solve an age-old problem: How to accurately diagnose brain diseases EARLY— decades before any symptoms.
Your test results propel science to drug breakthroughs for Alzheimer’s, Parkinson’s, and other brain diseases.
Every Alzheimer’s, Parkinson’s, and LBD patient is unique. To treat each individual properly, we need personalized medicine.
We must first solve an age-old problem: How to accurately diagnose brain diseases EARLY— decades before any symptoms.
Your test results propel science to drug breakthroughs for Alzheimer’s, Parkinson’s, and other brain diseases.
Claudio Soto, CoFounder & CSO
Claudio Soto, CoFounder & CSO
